doi: 10.1073/pnas.0709747104 49 El GaafaryMMoradSAFSchmiechMSyrovetsTSimmetT
Advances in metabolomics and molecular biology are expected to further uncover the complex interplay between metabolism and fibrosis, offering new opportunities for biomarker discovery, early diagnosis, and the development of targeted, personalized treatments for pulmonary fibrosis
For instance, its extract significantly inhibits the lipopolysaccharide (LPS)-induced transcription of inflammatory cytokines (TNF-, IL-1 and IL-6) in RAW 264.7 cellsa well-established in vitro model for innate immune screening (Zhao et al., 2021)
Proc Natl Acad Sci USA 1992
Although GSH-responsive nanomedicine shows great potential, several important areas require further study
Jungas T, Motta I, Duffieux F, Fanen P, Stoven V, Ojcius DM